Compare BLE & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLE | AVNS |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 499.7M | 521.7M |
| IPO Year | N/A | N/A |
| Metric | BLE | AVNS |
|---|---|---|
| Price | $10.54 | $15.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 108.3K | ★ 595.9K |
| Earning Date | 01-01-0001 | 02-20-2026 |
| Dividend Yield | ★ 4.46% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | N/A | ★ $699,900,000.00 |
| Revenue This Year | N/A | $3.07 |
| Revenue Next Year | N/A | $2.16 |
| P/E Ratio | $1,082.00 | ★ N/A |
| Revenue Growth | N/A | ★ 2.70 |
| 52 Week Low | $8.77 | $9.30 |
| 52 Week High | $10.95 | $16.78 |
| Indicator | BLE | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 54.93 | 77.53 |
| Support Level | $10.40 | $12.75 |
| Resistance Level | $10.61 | $14.61 |
| Average True Range (ATR) | 0.08 | 0.47 |
| MACD | 0.00 | 0.16 |
| Stochastic Oscillator | 68.29 | 96.84 |
Blackrock Municipal Income Trust II is a perpetual closed-end municipal bond fund. Its objective is to provide a high current income exempt from federal income taxes. The fund invests a majority of its managed assets in municipal obligations issued by or on behalf of states, territories, and possessions of the United States and their political subdivisions, agencies, or instrumentalities (Municipal Bonds), the interest of which is exempt from regular federal income tax (except that the interest may be subject to the alternative minimum tax).
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.